Butler Hospital

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Butler Hospital sits in the top decile of US sponsors by registered trial count (#237 of 15,742 sponsors by registered trial count).

103 total trials 9 currently recruiting 85 completed top decile by trial count

Butler Hospital: 103 sponsored US clinical trials, 9 recruiting.

Butler Hospital sponsors 103 registered US clinical trials on ClinicalTrials.gov, 9 of them currently recruiting, and 85 completed. 17 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 5 trials.

Top-decile sponsor footprint

Butler Hospital ranks in the top decile of sponsors by registered trial count (#237 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

B 84/100

85 of 87 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

103 total, page 2 of 3

COMPLETED NA

Initiating and Maintaining Physical Activity in Depressed Individuals

NCT02691845

COMPLETED NA

Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women

NCT02705898

COMPLETED NA

Behavioral Consultation for HIV+ Older Adults Prescribed Opioids for Chronic Pain

NCT02272829

COMPLETED NA

Healthy Expectations - a Program for Pregnant Women Experiencing Depressive Symptoms

NCT02474862

COMPLETED NA

Researching the Effectiveness of Acceptance-Based Coping During Hospitalization

NCT02336581

COMPLETED NA

Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons

NCT02316184

COMPLETED NA

Transcranial Direct Current Stimulation Augmented Exposure and Response Prevention for Obsessive-Compulsive Disorder

NCT02329587

COMPLETED NA

Evaluation of the Coping Long Term With Active Suicide Program

NCT02313753

COMPLETED NA

rTMS for PTSD Comorbid With Major Depressive Disorder

NCT02273063

COMPLETED NA

Assisting Obsessive Compulsive Disorder (OCD) Patients With Discontinuing Long-term Serotonin Reuptake Inhibitors (SRIs)

NCT02103621

COMPLETED NA

Women Engaging in Quitting Smoking Together (WE QUIT)

NCT02051803

COMPLETED NA

Computer MI for Tobacco Quitline Engagement in Smokers Living With HIV

NCT01886924

COMPLETED NA

The Health Check-Up for Expectant Moms

NCT02120716

COMPLETED NA

Exercise for Depressed Smokers

NCT02086149

COMPLETED NA

AA Linkage for Alcohol Abusing Women Leaving Jail

NCT01970293

COMPLETED NA

Preventing Bacterial and Viral Infections Among Injection Drug Users

NCT01892358

COMPLETED NA

Engaging HIV Patients in Primary Care by Promoting Acceptance

NCT02004457

COMPLETED NA

Program for Emotional and Physical Pain - Pilot Randomized Clinical Trial

NCT01769729

COMPLETED NA

Treating Chronic Pain and Depression in HIV+ Patients in Primary Care Settings

NCT01735708

COMPLETED NA

Linking Opioid Dependent Patients From Inpatient Detoxification to Primary Care

NCT01751789

COMPLETED NA

Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings

NCT01752998

COMPLETED NA

Motivating Quitline Use Among Smokers in Treatment for Substance Use Disorders

NCT01882673

COMPLETED Phase 3

Distress Tolerance and Buprenorphine

NCT01556087

COMPLETED Phase 3

Emerging Adults Who Use Alcohol and Marijuana

NCT01473719

COMPLETED Phase 2

Holistic Approaches to Depression

NCT01384916

COMPLETED Phase 2

Exercise and Health Intervention for Patients With Obsessive Compulsive Disorder (OCD)

NCT01242735

COMPLETED Phase 3

Linking Hospitalized Injection Drug Users to Buprenorphine

NCT00987961

COMPLETED NA

Coping Skills Treatment for Smoking Cessation

NCT01061528

COMPLETED NA

Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking

NCT00790569

COMPLETED Phase 3

Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms

NCT00578669

COMPLETED NA

Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers

NCT00525837

COMPLETED Phase 4

Eszopiclone Treatment & Cortisol Responsivity

NCT00889200

COMPLETED Phase 2

Culturally Sensitive Depression Care Management for Latino Primary Care Patients

NCT00571454

COMPLETED Phase 1

Randomized Trial of Psychotherapy for Persistently Depressed Primary Care Patients

NCT00541957

COMPLETED Phase 2

Mood Management Phone Counseling in Smoking Cessation

NCT00500877

COMPLETED Phase 3

SSRI and Buprenorphine

NCT00475878

COMPLETED

Interactive Voice Response (IVR) for Methadone Patients

NCT00237406

COMPLETED Phase 3

Insomnia and Drug Relapse Risk

NCT00253890

COMPLETED Phase 3

Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking

NCT00503230

COMPLETED Phase 1

Interpersonal Treatment Program to Prevent Depression and Post-Traumatic Stress Disorder in Low-Income Pregnant Women With Partner Abuse

NCT00602732

COMPLETED Phase 4

Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder

NCT00265109

COMPLETED Phase 3

A Brief Marijuana Intervention for Adolescent Women - 1

NCT00227864

COMPLETED Phase 2

Electrical Stimulation of the Internal Capsule for Intractable Depression

NCT01069952

COMPLETED Phase 1

Treatment of Depressed Women Who Have Been Sexually Abused

NCT00042237

COMPLETED Phase 1

Prevention of Postpartum Depression in Low-Income Women

NCT00053651

COMPLETED NA

Motivational Program for Smokers Enrolled in a Methadone Maintenance Program

NCT00278226

COMPLETED Phase 2

Electrical Stimulation of the Internal Capsule for Intractable Obsessive-compulsive Disorder (OCD)

NCT01061983

COMPLETED Phase 3

A Trial to Reduce Hepatitis C Among Injection Drug Users - 1

NCT00218192

COMPLETED Phase 3

Effectiveness of a Telephone Intervention Program in Improving Depression, Coping, and Family Functioning in HIV-Infected Individuals and Caregivers

NCT00183781

COMPLETED Phase 3

Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users

NCT00228007

← Previous Page 2 of 3 Next →

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 2 8
Phase 3 13
Phase 4 4

What is open in the Butler Hospital pipeline

9 recruiting of 103 indexed (9% open); 85 completed (83%).

Phase mix: 17 late (III/IV) vs 14 early (I/II) (balanced across stages).

Top condition: Depression (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Butler Hospital: open-pipeline peers nationwide

Peers matched on 103 registered trials and 9% open enrollment, not the therapeutic-area sidebar.

Butler Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 020406080100120 0%10%20%30%40% Total trials Recruiting share Butler HospitalBoston University Charles River CampusKessler FoundationVirginia Polytechnic Institute and State UniversityJohnson & Johnson Pharmaceutical Research & Development, L.L.C.AMAG PharmaceuticalsIowa State UniversityNew Approaches to Neuroblastoma Therapy ConsortiumRhythm Pharmaceuticals
Butler Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Butler Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 103 trials (± recruiting share)

Sponsors near 9% open enrollment (± trial volume)

What to do with this Butler Hospital page

103 registered trials is a research-attention snapshot, not an endorsement of Butler Hospital or any single study.

  • 9 of Butler Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Butler Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Butler Hospital pipeline card: 103 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.